Main

The 2012 Annual Meeting is sold out.

Towards Next-Generation
Cancer Immunotherapy
May 23 – 25, 2012
Mainz, Germany

The abstract book is now availabe for download

Pre-Payment Deadline:
May 18, 2012*

*There will be an additional processing fee of EUR  30
for registrations after May 18.

Confirmed Speakers

• Carl June (University of Pennsylvania)
• Pramod K. Srivastava (University of Connecticut)
• Shizuo Akira (Osaka University)
• Michael Nishimura (Loyola University Medical Center)
• Robert Vonderheide (University of Pennsylvania School of Medicine)
• Tibor Keler (Celldex Therapeutics)
• Klaus Pantel (Universitätsklinikum Hamburg-Eppendorf)
• Jerôme Galon (INSERM)
• Sjoerd van der Burg (Leiden University Medical Center)
• Michael Kalos (University of  Pennsylvania School of Medicine)
• Wolfgang Herr (University Medical Center Mainz)
• Hansjörg Schild (Forschungszentrum Immunology Mainz)
• Patrick A. Baeuerle (Micromet AG)
• Antonio Lanzavecchia (Institute for Research in Biomedicine)
• Mark X. Sliwkowski (Genentech)
• Samir N. Khleif (NIH Cancer Vaccine Section)
• Jay A. Berzofsky (National Cancer Institute)
• Laurence Zitvogel (INSERM)
• James P. Allison (Memorial Sloan Kettering Cancer Center)
• Scott Tanner (University of Toronto)
• Kyogo Itoh (Kurume University)
• Thomas F. Gajewski (SITC)
• Martin Glennie(Southampton General Hospital)
• Rienk Offringa (German Cancer Research Center)
• Ugur Sahin (TRON)
• Richard Scheuermann (UT Southwestern Medical Center)
• John Castle (TRON)
• Robert Kralovics (Austrian Research Center for Molecular Medicine)
• Zlatko Trajanoski (Innsbruck Medical University)
• Patrick Hwu (University of Texas)
• Peter Bross (FDA)
• Bruno Flamion (University of Namur)

Program Committee

• S. Kreiter (CIMT Executive Director Science, TRON-Translational Oncology, Mainz)
• C. Britten(CIMT Executive Director Translational Medicine, Ribological, Mainz)
• M. Diken (CIMT Scientific Secretary, TRON-Translational Oncology, Mainz)
• A. Hoos (CRI-CIC, Glaxo Smith Kline, New York)
• D. Schendel (Institute for Molecular Immunology, Helmholtz Center, Munich)
• M.Theobald (3rd Medical Department, University Medical Center Mainz)
• C. Gouttefangeas (CIMT Immunoguiding Program, University of Tübingen)
• U. Kalinke (Twincore, Hanover)
• H. J. Schild (Institute for Immunology, University Medical Center Mainz)
• W. Herr (3rd Medical Department, University Medical Center Mainz)